Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Ustekinumab and Omalizumab

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 2 releases in its history.

Award

11 Sep 2024 at 16:09

Award Notice
Tender

28 Jun 2024 at 10:28

Tender Notice
Summary of the contracting process

The Common Services Agency, known as NHS National Services Scotland (NSS), has successfully awarded a contract for the supply of Ustekinumab and Omalizumab, classified under pharmaceutical products (CPV code 33600000). This procurement process, which is now in its award stage, involves the delivery of these medicinal products to NHS Scotland, including entities established by the National Health Service (Scotland) Act 1978 and Integrated Joint Boards formed under the Public Bodies (Joint Working) Scotland Act 2014. Notably, the contract for Ustekinumab, valued at £11,680,128, and for Omalizumab, valued at £2,136,450, was signed on 21 August 2024. The procurement utilized an open procedure method and resulted in an unranked multi-supplier framework, with a framework agreement lasting up to 24 months from 1 October 2024, with extension options for an additional 24 months if required.

This procurement provides significant opportunities for businesses, especially for suppliers within the pharmaceutical industry. The framework allows up to six suppliers for Ustekinumab and three for Omalizumab, enhancing the market involvement of both large-scale enterprises and SMEs. Companies possessing UK Marketing Authorisations that comply with MHRA regulations and maintaining BS EN ISO 9001 certifications are well-suited to compete in this tender. Additionally, suppliers can anticipate stable, long-term engagements due to the framework's potential extensions, thereby fostering growth and stability for their businesses. The involvement of multiple suppliers and substantial contract values highlight the opportunity for businesses keen on expanding their footprint within the public healthcare sector.

How relevant is this notice?

Notice Information

Notice Title

Ustekinumab and Omalizumab

Notice Description

Supply of Ustekinumab and Omalizumab to NHS Scotland

Lot Information

Ustekinumab

Supply of Ustekinumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to a six (6) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Omalizumab

Supply of Omalizumab presentations to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework per product line to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of twenty-four (24) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-047344
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/029144-2024
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£70,000,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£13,816,578 £10M-£100M

Notice Dates

Publication Date
11 Sep 20241 years ago
Submission Deadline
29 Jul 2024Expired
Future Notice Date
Not specified
Award Date
21 Aug 20242 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
7
Supplier Names

Accord Healthcare Ltd

Amgen Ltd

Celltrion Healthcare United Kingdom Limited

Janssen-Cilag Ltd

Novartis Pharmaceuticals UK Ltd

STADA UK - Thornton & Ross

Sandoz

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...